Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
QURE compared with TSHA: revenue, margins and what each company keeps, and the suppliers and customers both name
QURE
uniQure N.V.
Change
Mkt cap
Revenue
Revenue
TSHA
Taysha Gene Therapies, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
QURE
uniQure N.V.
vs
TSHA
Taysha Gene Therapies, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only QURE
9
FDMT
4D Molecular Therapeutics
supplier
RGNX
Regenxbio
supplier
—
Apic Bio
unlisted
supplier
—
Cold Spring Harbor Laboratory
unlisted
supplier
5 more · QURE chain
›
Shared
0
No shared counterparties.
Only TSHA
10
ABEO
Abeona
supplier
—
The Board of Regents of the University of Texas System on behalf of The University of Texas Southwestern Medical Center
unlisted
supplier
—
The Board of Regents of the University of Texas System on behalf of UT Southwestern
unlisted
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
supplier
—
University of North Carolina at Chapel Hill
unlisted
supplier
6 more · TSHA chain
›
QURE
uniQure N.V.
Change
23.88
▲
+3.94%
· post 23.88
· delayed
Mkt cap
$1.6B
Revenue
$6M
Q2 FY26
Revenue
$16M
FY25
TSHA
Taysha Gene Therapies, Inc.
Change
4.08
▲
+2.00%
· post 4.08
· delayed
After hours
Nov 3 '26
delayed
Mkt cap
$1.3B
Revenue
$5M
Q4 FY25
Revenue
$8M
FY24
vs
Compare
After hours
Nov 3 '26
delayed
QURE
uniQure N.V.
vs
TSHA
Taysha Gene Therapies, Inc.
23.88
▲
+3.94%
post 23.88
delayed
Price
4.08
▲
+2.00%
post 4.08
delayed
$1.6B
Mkt cap
$1.3B
Q2 FY26
$6M
Revenue
$5M
Q4 FY25
FY25
$16M
Revenue
$8M
FY24
Change
Change
QURE
23.88
▲
+3.94%
vs
TSHA
4.08
▲
+2.00%
After hours
Nov 3 '26
delayed